<sequence-cwu id="SEQLST-1">
<publication-reference>
<document-id>
<country>US</country>
<doc-number>07297343</doc-number>
<kind>B2</kind>
<date>20071120</date>
</document-id>
</publication-reference>
<number>1</number>
<sequence-list-new-rules>
<s100>
<s160>4 </s160>
</s100>
<s200>
<s210>1 </s210>
<s211>28 </s211>
<s212>PRT </s212>
<s213>Artificial </s213>
<s220>
<s223>Synthetic FGF-2 analog</s223>
</s220>
</s200>
<s400> 1 
Asn Arg Phe His Ser Trp Asp Cys Ile Lys Thr Trp Ala Ser Asp Thr 
1               5                   10                  15 
Phe Val Leu Val Cys Tyr Asp Asp Gly Ser Glu Ala 
            20                  25 
</s400>
<s200>
<s210>2 </s210>
<s211>10 </s211>
<s212>PRT </s212>
<s213>Artificial </s213>
<s220>
<s223>Heparin binding domain</s223>
</s220>
</s200>
<s400> 2 
Arg Lys Arg Lys Leu Glu Arg Ala Ile Arg 
1               5                   10 
</s400>
<s200>
<s210>3 </s210>
<s211>5 </s211>
<s212>PRT </s212>
<s213>Artificial </s213>
<s220>
<s223>Laminin basement membrane derived protein</s223>
</s220>
</s200>
<s400> 3 
Ile Lys Val Ala Val 
1               5 
</s400>
<s200>
<s210>4 </s210>
<s211>5 </s211>
<s212>PRT </s212>
<s213>Artificial </s213>
<s220>
<s223>Laminin basement membrane derived protein</s223>
</s220>
</s200>
<s400> 4 
Tyr Ile Gly Ser Arg 
1               5
</s400>
</sequence-list-new-rules>
</sequence-cwu>
